Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jaccao.2020.04.002 http://scihub22266oqcxt.onion/10.1016/j.jaccao.2020.04.002 32313885!7164888!32313885     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       JACC+CardioOncol 2020 ; 2 (2): 254-269 Nephropedia Template TP {{tp|p=32313885|t=2020. COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities |pdf=|usr=}}{{32313885}} gab.com Text COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities JO: JACC CardioOncol http://www.kidney.de/pget.php?&tw=1&pmid=32313885 #FOAvip The coronavirus disease-2019 (COVID-19) pandemic has resulted in a proliferation of clinical trials designed to slow the spread of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). Many therapeutic agents that are being used to treat patients with COVID-19 are repurposed treatments for influenza, Ebola, or for malaria that were developed decades ago and are unlikely to be familiar to the cardiovascular and cardio-oncology communities. Here, we provide a foundation for cardiovascular and cardio-oncology physicians on the front line providing care to patients with COVID-19, so that they may better understand the emerging cardiovascular epidemiology and the biological rationale for the clinical trials that are ongoing for the treatment of patients with COVID-19. Twit Text FOAVip COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities ????JACC CardioOncol http://www.kidney.de/pget.php?&tw=1&pmid=32313885 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32313885 #FOAvip English Wikipedia <ref>{{Cite pmid|32313885}}</ref> COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities #MMPMID32313885 Ky B; Mann DL JACC CardioOncol 2020[Jun]; 2 (2): 254-269 PMID32313885show ga The coronavirus disease-2019 (COVID-19) pandemic has resulted in a proliferation of clinical trials designed to slow the spread of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). Many therapeutic agents that are being used to treat patients with COVID-19 are repurposed treatments for influenza, Ebola, or for malaria that were developed decades ago and are unlikely to be familiar to the cardiovascular and cardio-oncology communities. Here, we provide a foundation for cardiovascular and cardio-oncology physicians on the front line providing care to patients with COVID-19, so that they may better understand the emerging cardiovascular epidemiology and the biological rationale for the clinical trials that are ongoing for the treatment of patients with COVID-19. äCOVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-O(epmc).pdf DeepDyve Pubget Overpricing